Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment

Objective: To evaluate the differences in the outcome of lupus nephritis diagnosed either in the 1980s or the 1990s in Heidelberg, Germany. Methods: Fifteen patients with biopsy confirmed lupus nephritis (LN) were followed up between 1980 and 1989 and 41 patients were followed up between 1990 and 2000. Their status at diagnosis and their treatment schedules and outcome were analysed. 68% had WHO IV nephritis. Results: In the decade from 1990 to 2000 there was significantly less proteinuria (46 v 17 g/l, p=0.008), significantly lower rates of renal failure (40% v 17%, p=0.02), and fewer histological signs of chronicity (33% v 10%, p=0.01) at the time of diagnosis of LN than in the decade from 1980 to 1989. The mean (SD) time from the first appearance of proteinuria until kidney biopsy was significantly shorter in the later decade (15.4 (15.6) v 3.9 (4.7) months). Although treatment schedules were not significantly different, the outcome of the disease was significantly better in the patients who were diagnosed with LN between 1990 and 2000 (p=0.045). Whereas 6/15 (40%) patients between 1980 and 1989 had terminal renal failure after a mean time of 94 months, in the group of 1990–2000 no patient developed terminal renal failure (median observation time 24 months). In both groups one patient died from infection. A high chronicity index in histology and the presence of arterial hypertension or renal failure, or both, at the time of diagnosis were significant risk factors for the development of terminal renal failure in the course of the disease. Conclusions: The outcome of patients with newly diagnosed LN was significantly better between 1990 and 2000 than between 1980 and 1989. Kidney damage and chronic histological changes at time of diagnosis were significantly less common between 1990 and 2000, which is attributable to earlier diagnosis and treatment in the later decade.

[1]  D. Gladman,et al.  Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. , 1995, The Journal of rheumatology.

[2]  C. Jacob,et al.  Prognostic factors in diffuse proliferative lupus nephritis. , 1999, The Journal of the Association of Physicians of India.

[3]  S. Studenski,et al.  Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. , 1992, Archives of internal medicine.

[4]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[5]  J. Balfe,et al.  Correlation of renal histology with outcome in children with lupus nephritis. , 1986, Kidney international.

[6]  J Thumboo,et al.  Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. , 1999, Arthritis and rheumatism.

[7]  G. Hughes,et al.  Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. , 1999, Medicine.

[8]  C. Vasconcelos,et al.  Lupus nephritis: a retrospective review of 78 cases from a single center. , 2002, Clinical nephrology.

[9]  M. Jadoul,et al.  Cytotoxic therapy of lupus nephritis: recent developments. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  Y. Levy,et al.  Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. , 2002, Arthritis and rheumatism.

[11]  D. Gladman,et al.  Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. , 1995, The Journal of rheumatology.

[12]  D. Gladman,et al.  Evolving spectrum of mortality and morbidity in SLE , 1999, Lupus.

[13]  D. Nash,et al.  Renal Disease: Classification and Atlas of Glomerular Diseases , 1983 .

[14]  Joni K. Evans,et al.  Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. , 2001, Kidney international.

[15]  D. Boumpas,et al.  High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  D. Gladman,et al.  Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. , 1997, The Journal of rheumatology.

[17]  B. Haynes,et al.  Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. , 1983, Annals of internal medicine.

[18]  J. Cameron,et al.  Lupus Nephritis , 1959, Clinics in rheumatic diseases.

[19]  S. Quaglini,et al.  "Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis. , 1996, Kidney international.

[20]  Role of pathology indices in the management of severe lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group. , 1992, Kidney international.

[21]  R Fischer,et al.  Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation , 2001, Lupus.

[22]  J. Cameron,et al.  The very long-term prognosis and complications of lupus nephritis and its treatment. , 1999, QJM : monthly journal of the Association of Physicians.

[23]  D. Sackett,et al.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.

[24]  G. Hughes,et al.  Morbidity and mortality in systemic lupus erythematosus during a 5-year period - A multicenter prospective study of 1,000 patients , 1999 .

[25]  A. Steinberg,et al.  Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis , 1992, The Lancet.

[26]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[27]  T. Kvien,et al.  Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years. , 2001, The Journal of rheumatology.